Literature DB >> 4060103

Chemotherapy in non-small cell bronchial carcinoma.

R Souhami.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4060103      PMCID： PMC460162          DOI： 10.1136/thx.40.9.641

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  26 in total

1.  MACC (methotrexate, adriamycin, cyclophosphamide and CCNU) in advanced lung cancer.

Authors:  A P Chahinian; E M Mandel; J F Holland; I S Jaffrey; A S Teirstein
Journal:  Cancer       Date:  1979-05       Impact factor: 6.860

2.  Adriamycin in the treatment of far-advanced lung cancer.

Authors:  E W Knight; S Lagakos; L Stolbach; J Colsky; J Horton; L Israel; J Bennett; C Perlia; W Regelson; P P Carbone
Journal:  Cancer Treat Rep       Date:  1976-07

3.  Ifosfamide in the treatment of recurrent or disseminated lung cancer: a phase II study of two dose schedules.

Authors:  J J Costanzi; R Gagliano; D Loukas; F J Panettiere; J A Hokanson
Journal:  Cancer       Date:  1978-05       Impact factor: 6.860

4.  Methotrexate compared with placebo in lung cancer.

Authors:  O Selawry; M Krant; J Scotto; E Kazam; M Schneiderman; K Olson; B Shnider; J Edmonson; J Holland; S Taylor
Journal:  Cancer       Date:  1977-07       Impact factor: 6.860

5.  Oral high-dose methotrexate with citrovorum factor rescue in metastastic squamous cell carcinoma of the lung.

Authors:  K Tornyos; H Faust
Journal:  Cancer       Date:  1978-02       Impact factor: 6.860

6.  Chemotherapy for metastatic non-small-cell bronchogenic carcinoma: EST 2575, generation V--a randomized comparison of four cisplatin-containing regimens.

Authors:  J C Ruckdeschel; D M Finkelstein; B A Mason; R H Creech
Journal:  J Clin Oncol       Date:  1985-01       Impact factor: 44.544

Review 7.  The role of chemotherapy in the treatment of lung cancer.

Authors:  O S Selawry
Journal:  Semin Oncol       Date:  1974-09       Impact factor: 4.929

8.  BACON (bleomycin, adriamycin, CCNU, oncovin and nitrogen mustard) in squamous lung cancer. Experience in fifty patients.

Authors:  R B Livingston; W H Fee; L H Einhorn; M A Burgess; E J Freireich; J A Gottlieb; M O Farber
Journal:  Cancer       Date:  1976-03       Impact factor: 6.860

9.  Cyclophosphamide and CCNU in the treatment of inoperable small cell carcinoma and adenocarcinoma of the lung.

Authors:  J H Edmonson; S W Lagakos; O S Selawry; C P Perlia; J M Bennett; F M Muggia; G Wampler; H S Brodovsky; J Horton; J Colsky; E G Mansour; R Creech; L Stolbach; E M Greenspan; M Levitt; L Israel; E Z Ezdinli; P P Carbone
Journal:  Cancer Treat Rep       Date:  1976-07

10.  Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP).

Authors:  J D Bitran; R K Desser; T DeMeester; H M Golomb
Journal:  JAMA       Date:  1978-12-15       Impact factor: 56.272
View more
  1 in total

Review 1.  Chemotherapy plus best supportive care versus best supportive care in patients with non-small cell lung cancer: a meta-analysis of randomized controlled trials.

Authors:  Chenxi Zhong; Hongcheng Liu; Liyan Jiang; Wei Zhang; Feng Yao
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.